GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (NSE:INDOCO) » Definitions » Interest Expense

Indoco Remedies (NSE:INDOCO) Interest Expense : ₹-594 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Indoco Remedies's interest expense for the three months ended in Dec. 2024 was ₹ -161 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-594 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Indoco Remedies's Operating Income for the three months ended in Dec. 2024 was ₹ -167 Mil. Indoco Remedies's Interest Expense for the three months ended in Dec. 2024 was ₹ -161 Mil. Indoco Remedies did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Indoco Remedies Interest Expense Historical Data

The historical data trend for Indoco Remedies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies Interest Expense Chart

Indoco Remedies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.03 -210.41 -164.58 -237.50 -370.79

Indoco Remedies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.70 -111.09 -143.10 -178.30 -161.10

Indoco Remedies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-594 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indoco Remedies  (NSE:INDOCO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Indoco Remedies's Interest Expense for the three months ended in Dec. 2024 was ₹-161 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹-167 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Indoco Remedies's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Indoco Remedies did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Indoco Remedies Ltds earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.


Indoco Remedies Business Description

Traded in Other Exchanges
Address
166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines